Results 91 to 100 of about 3,321,782 (156)

Ovarian malignant mixed Müllerian tumor: a rare case report from Tanzania. [PDF]

open access: yesJ Surg Case Rep, 2020
Pallangyo A   +9 more
europepmc   +1 more source

Polysomy 8 in three cases of homologous malignant mixed mullerian tumors of the uterus

open access: yes, 2003
Unique genetical gain of 8q and/or polysomy 8 identified after short-term culture are presented in three cases of malignant mixed Mullerian tumors (MMMT) of the uterus.
Fuzesi, Laszlo   +4 more
core   +2 more sources

Uterine Sarcomas in Siriraj Hospital (1991-2005)

open access: yesSiriraj Medical Journal, 2006
Objective: To study the incidence, clinical characteristics, treatments and outcomes in patients with uterine sarcomas at Siriraj Hospital. Methods: A medical record search of patients treated at Siriraj Hospital from January 1991 to December 2005 was ...
Atthapon Jaishuen   +5 more
doaj  

Unveiling ovarian carcinosarcoma: A case report on management and evolutionary insights

open access: yesAnnals of Oncology Research and Therapy
Ovarian carcinosarcoma (OCS), also known as malignant mixed Müllerian tumor, is a rare and highly aggressive form of ovarian neoplasm, accounting for
Safae Toumi   +3 more
doaj   +1 more source

Malignant mixed mesodermal tumor of the ovary [PDF]

open access: yes, 1980
Mixed mesenchymal and epithelial tumors are highly malignant neoplasms most commonly found in the uterus. Rarely, histologically identical tumors occur in the ovary. We report a 70-yr-old woman with a malignant mixed Müllerian tumor of the ovary.
Wagenaar, S.S., Elbers, J.R.J.
core  

Malignant mixed mullerian tumour of the endometrium with a synchronous ovarian cancer- a rare association [PDF]

open access: yes, 2016
Synchronous malignancies of genital tract are extremely uncommon especially those with independent histopathologies. We are reporting a rare case with a unique presentation.
Chennaihgari, Sathyavani   +4 more
core  

Exposure to Abnormal Self Antigens During Non-Malignant Inflammatory Events Provides Immunological Defense Against Tumors [PDF]

open access: yes, 2013
Cancer immunosurveillance is the body’s sentinel mechanism of recognizing and eliminating malignancy. Specifically, the immune system can mount a response against cancer through the recognition of tumor associated antigens (TAA). While studying two TAAs,
Iheagwara, Uzoma
core  

Rare primary malignant mixed Müllerian tumor of the mediastinum: A case report. [PDF]

open access: yesMedicine (Baltimore), 2018
Wang C, Liu R, Huang F, Wei H, Yu L.
europepmc   +1 more source

Home - About - Disclaimer - Privacy